Xiuyan Wang
Director - Cell Therapy & Cell Engineering Core Memorial Sloan Kettering Cancer Center
Xiuyan Wang is Director of the BioTherapeutics Core Facility at Memorial Sloan Kettering Cancer Center. She has a demonstrated record of developing and advancing cell therapy for T cells and haematopoietic stem cells from pre-clinical stage to phase I/II clinical trials. She has over 18 years of hands-on cGMP experience supporting 20+ phase I/II clinical trials, with extensive expertise in CMC, FDA and NIH regulations, and large-scale manufacturing of clinical-grade viral vectors and gene-edited cell therapies.
Seminars
Automated manufacturing is emerging as the industry’s clearest path to lower COGs, broader patient access and sustainable commercial success.
In this focused session, evaluate where automation delivers the greatest value in your manufacturing process, how to integrate it into your existing framework and how to align with regulations. Through case studies and in-depth discussions, combining industry leaders involved in automated manufacturing and key regulatory experts, gain insight into the decisions, trade-offs and lessons shaping automated manufacturing programmes to de-risk execution and ensure a smooth and economical road to market.
- Analyzing the impact of automation on cost of goods to optimize resource allocation and support sustainable clinical and commercial manufacturing
- Integrating automated platforms within GMP manufacturing and quality systems while maintaining data integrity and oversight
- Interpreting updated cell therapy GMP and advanced manufacturing technology expectations to leverage regulatory flexibility without compromising compliance
- Discussing strategies to achieve the highest yield with automated manufacturing
- Exploring the stage of development at which to introduce automation
- Showcasing data achieved using automated manufacturing processes in CAR-T and CARNK therapies
- Exploring the adoption of automated manufacturing process to enhance consistency, output and decrease variability
- Examining integration and flexibility challenges in automation to inform realistic implementation strategies
- Analyzing the impact of automation on cost of goods to optimize resource allocation and support sustainable clinical and commercial manufacturing
